NCT06936202 Effects of Spirulina Supplementation on Mental Health in Healthy Adults
| NCT ID | NCT06936202 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Arizona State University |
| Condition | Depression |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-04-15 |
| Primary Completion | 2026-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2025-04-15 with a primary completion date of 2026-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Spirulina platensis is a form of cyanobacteria, a blue-green algae, and is a superfood most known for being rich in protein, vitamins and minerals, and healthful phytochemicals. Spirulina supports brain health through neuroprotection offered by its antioxidants, anti-inflammatory properties, and hormone regulation. The aim of this study is to supplement healthy adults from a campus community with 3g of spirulina, daily, for 8 weeks to improve mood and mental acuity in comparison to receiving a placebo.
Eligibility Criteria
Inclusion Criteria: * healthy adults * ages 18-65 * no underlying chronic disease or acute conditions * no autoimmune conditions * do not consume alcohol in excess, smoke, use recreational drugs * does not follow restrictive diets * will be recruited from the ASU university campus. Exclusion Criteria: * not have been clinically diagnosed with depression * not taking antidepressants, anxiety, or stress medications, or any other medications * drugs, or supplements that could influence mental capacities * not pregnant or breastfeeding * not a competitive athlete
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06936202 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 65 Years, studying Depression. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06936202 currently recruiting?
Yes, NCT06936202 is actively recruiting participants. Contact the research team at carol.johnston@asu.edu for enrollment information.
Where is the NCT06936202 trial being conducted?
This trial is being conducted at Phoenix, United States.
Who is sponsoring the NCT06936202 clinical trial?
NCT06936202 is sponsored by Arizona State University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.